Filing Details
ANI PHARMACEUTICALS INC (NASDAQ:ANIP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ANIP
ANI PHARMACEUTICALS INC (ANIP) Files Quarterly Report for Q0
ANI PHARMACEUTICALS INC (NASDAQ:ANIP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
ANI PHARMACEUTICALS INC (NASDAQ:ANIP) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- ANI Pharmaceuticals Inc (NASDAQ: ANIP) filed its quarterly report (Form 10-Q) with the SEC on August 07, 2026.
- The company's stock trades at $78.25 with a market capitalization of $1.7 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including information about emerging trends and updated risk factors.
Market Context
ANI PHARMACEUTICALS INC's stock currently trades at $78.25 with a market capitalization of $1.7B.
The 10-Q provides ANI PHARMACEUTICALS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for ANI PHARMACEUTICALS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ANIP Stock Page
Frequently Asked Questions
Where can I read ANIP's SEC filings?
Browse all filings on our ANIP SEC filings page.
What types of SEC filings does ANI PHARMACEUTICALS INC file?
Public companies like ANI PHARMACEUTICALS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.